131 related articles for article (PubMed ID: 24824555)
1. Biological variation of immunoglobulin heavy chain-light chain pairs in serum.
Finlay JA; Wu AH
Clin Chim Acta; 2014 Sep; 436():68-71. PubMed ID: 24824555
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
[TBL] [Abstract][Full Text] [Related]
3. Heavy/light chain assay in the monitoring of multiple myeloma.
Ting HY; Sthaneshwar P; Bee PC; Shanmugam H; Lim M
Pathology; 2019 Aug; 51(5):507-511. PubMed ID: 31253381
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic performance of κ/λ serum free light chain ratio (Freelite® assay) and IgGκ/IgGλ ratio (Hevylite® assay) as prognostic biomarkers of the evolution of immune thrombocytopenia into a chronic disease in adult patients].
Martellosio JP; Barra A; Roy-Peaud F; Souchaud-Debouverie O; Martin M; Lateur C; Gombert JM; Roblot P; Puyade M
Rev Med Interne; 2020 Jan; 41(1):3-7. PubMed ID: 31722837
[TBL] [Abstract][Full Text] [Related]
5. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
6. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.
Katzmann JA; Willrich MA; Kohlhagen MC; Kyle RA; Murray DL; Snyder MR; Rajkumar SV; Dispenzieri A
Clin Chem; 2015 Feb; 61(2):360-7. PubMed ID: 25451866
[TBL] [Abstract][Full Text] [Related]
7. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the diagnostic performances of IgA heavy and light chain pairs in patients with IgA monoclonal gammopathy.
Wolff F; Debaugnies F; Rozen L; Willems D; Brohet F; Brauner J; Stordeur P
Clin Biochem; 2013 Jan; 46(1-2):79-84. PubMed ID: 23041246
[TBL] [Abstract][Full Text] [Related]
9. Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays.
Kaleta E; Kyle R; Clark R; Katzmann J
Clin Chem Lab Med; 2014 May; 52(5):665-9. PubMed ID: 24327529
[TBL] [Abstract][Full Text] [Related]
10. Within-subject biological variation of pairs of heavy/light immunoglobulin IgM chains (HLC IgM κ and λ) is low and requires monitoring: A comparison with HLC IgA, HLC IgG, and free light immunoglobulin chains (FLC) in healthy subjects.
Jabor A; Kubíček Z; Komrsková J; Sečník P; Vacková T; Vymětalík J; Franeková J
Clin Chim Acta; 2018 Nov; 486():311-312. PubMed ID: 30125534
[No Abstract] [Full Text] [Related]
11. Immunofluorescence staining for immunoglobulin heavy chain/light chain on kidney biopsies is a valuable ancillary technique for the diagnosis of monoclonal gammopathy-associated kidney diseases.
Nasr SH; Fidler ME; Said SM; Koepplin JW; Altamirano-Alonso JM; Leung N
Kidney Int; 2021 Jul; 100(1):155-170. PubMed ID: 33774084
[TBL] [Abstract][Full Text] [Related]
12. Estimation of serum M-protein concentration from polyclonal immunoglobulins: an alternative to serum protein electrophoresis and standard immunochemical procedures.
Bergón E; Miravalles E
Clin Chem Lab Med; 2008; 46(8):1156-62. PubMed ID: 18605957
[TBL] [Abstract][Full Text] [Related]
13. IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.
Boyle E; Manier S; Lejeune J; Fouquet G; Guidez S; Bonnet S; Debarri H; Demarquette H; Dulery R; Gay J; Hennache B; Onraed B; Faucompré JL; Schraen S; Facon T; Avet-Loiseau H; Chevret S; Leblond V; Harding S; Leleu X
Clin Cancer Res; 2016 Oct; 22(20):5152-5158. PubMed ID: 27169996
[TBL] [Abstract][Full Text] [Related]
14. Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome.
Wang C; Su W; Zhang W; Di Q; Duan MH; Ji W; Cao XX; Zhou DB; Li J
Ann Hematol; 2014 Jul; 93(7):1201-6. PubMed ID: 24482101
[TBL] [Abstract][Full Text] [Related]
15. Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2012; 71(4):183-200. PubMed ID: 23755700
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of serum immunoglobulin heavy/light chain ratio in patients with multiple myeloma in complete remission after autologous stem cell transplantation.
Tovar N; Fernández de Larrea C; Elena M; Cibeira MT; Aróstegui JI; Rosiñol L; Filella X; Yagüe J; Bladé J
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1076-9. PubMed ID: 22430087
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Heavy/Light Chain Ratio and Matched Pair Suppression Increase Residual Disease Detection Sensitivity in Patients With Multiple Myeloma With Deep Responses.
Miyazaki K; Suzuki K
Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):293-296. PubMed ID: 29472112
[TBL] [Abstract][Full Text] [Related]
18. A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain.
Tadmor T; Braester A; Najib D; Aviv A; Herishanu Y; Yuklea M; Shvidel L; Rahimi-Levene N; Ruchlemer R; Arad A; Fogl C; Henig C; Barak M; Magal L; Polliack A; Townsend K;
Eur J Haematol; 2019 Oct; 103(4):335-341. PubMed ID: 31278876
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin heavy chain/light chain pairs (HLC, Hevylite™) assays for diagnosing and monitoring monoclonal gammopathies.
Kraj M
Adv Clin Exp Med; 2014; 23(1):127-33. PubMed ID: 24596015
[TBL] [Abstract][Full Text] [Related]
20. Quantification of β-region IgA monoclonal proteins - should we include immunochemical Hevylite® measurements? Point.
Evans JA; Jenner EL; Carr Smith HD; Berlanga O; Harding SJ
Clin Chem Lab Med; 2016 Jun; 54(6):1053-7. PubMed ID: 26485749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
